Filing Details

Accession Number:
0001209191-19-029376
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-05-13 16:59:44
Reporting Period:
2019-05-09
Accepted Time:
2019-05-13 16:59:44
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1180262 Herbalife Nutrition Ltd. HLF Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1472187 Edi Hienrich 800 W. Olympic Blvd. Suite 406
Los Angeles CA 90015
Svp/Managing Director Emea No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-05-09 3,930 $31.26 12,504 No 4 M Indirect By wife
Common Stock Disposition 2019-05-09 3,192 $48.47 9,312 No 4 F Indirect By wife
Common Stock Disposition 2019-05-13 738 $47.62 8,574 No 4 S Indirect By wife
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Indirect By wife
No 4 F Indirect By wife
No 4 S Indirect By wife
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Appreciation Rights Disposition 2019-05-09 3,930 $0.00 3,930 $31.26
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2019-05-09 2026-05-09 No 4 M Indirect
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 22,246 Direct
Footnotes
  1. This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person's wife.
  2. The Reporting Person's wife received 738 shares of common stock upon the net exercise of 3,930 stock appreciation rights ("SARs"). She forfeited 2,535 shares of common stock underlying the SARs in payment of the exercise price and 657 shares of common stock underlying the SARs to satisfy the withholding tax obligations resulting from the exercise, using the closing stock price on May 9, 2019 of $48.47.
  3. These SARS were previously reported as 1,965 shares at an exercise price of $62.51 per share, but were adjusted to reflect the stock split that occurred on May 14, 2018.